Journal for ImmunoTherapy of Cancer (Aug 2021)

Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

DOI
https://doi.org/10.1136/jitc-2021-002568corr1
Journal volume & issue
Vol. 9, no. 8

Abstract

Read online

No abstracts available.